Form 8-K - Current report:
SEC Accession No. 0001493152-24-049461
Filing Date
2024-12-10
Accepted
2024-12-10 16:05:37
Documents
14
Period of Report
2024-12-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38995
2 ex99-1.htm EX-99.1 16949
  Complete submission text file 0001493152-24-049461.txt   232451

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vbiv-20241210.xsd EX-101.SCH 3024
4 XBRL LABEL FILE vbiv-20241210_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE vbiv-20241210_pre.xml EX-101.PRE 24171
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3489
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 241538489
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)